Ovidrx
New York, US · Founded 2014 · 43 employees on LinkedIn · 2 known investors
Ovid Therapeutics develops medicines for children and adults with epilepsies and brain conditions, focusing on anti-seizure and neurological treatments. The company is led by a team with decades of combined experience in biotech and pharmaceutical development, having supported the launch of more than 25 new medicines.
Founders & leadership
Ovidrx was founded in 2014 by Jeremy M. Levin.
JM
MA
Meg AlexanderinPresident & Chief Executive Officer
CC
Charles CarterinChief Financial Officer
VF
Victoria FortinChief Strategy Officer
PK
MM
Manal MorsyinChief Regulatory Officer
KN
Kevin NorrettinChief Business Officer
ZZ
Zhong ZhonginChief Scientific Officer
JT
Julia TsaiinSenior Vice President of Clinical Development
Board
ES
Eliseo SalinasSenior R&D Advisor
Investors · 2
Frequently asked questions
- What does Ovidrx do?
- Ovid Therapeutics develops medicines for children and adults with epilepsies and brain conditions, focusing on anti-seizure and neurological treatments. The company is led by a team with decades of combined experience in biotech and pharmaceutical development, having supported the launch of more than 25 new medicines.
- Who founded Ovidrx?
- Ovidrx was founded by Jeremy M. Levin in 2014.
- Who are Ovidrx's investors?
- Ovidrx's investors include BioBrit, Sanofi Ventures.
- Where is Ovidrx headquartered?
- Ovidrx is headquartered in New York, US.